HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

893.450

-19.329-2.12%

Number of Gainers:1

Number of Losers:16

Number of Flat:- -

PE:- -

High:911.751

Open:911.751

Low:887.660

Close:912.778

Volume:295.80M

Turnover:2.20B

Market Cap:602.67B

Float Cap:500.27B

Loading ...

Hong Kong Market Flash | CSPC Pharma Drops Over 4% as Lp(a) HORIZON Study Setback May Pressure Participants Including the Company

CSPC Pharma's Clinical Data Presentations Could be Near-Term Share Catalysts

Morning Selloff Hits Mobile Supply Chain Stocks as Apple's Launch Fails to Offset Cost Pressures

Ascletis Pharma Surges on US Obesity Drug Trial Launch

Pharmaceutical Firms Divest Assets to Bolster Core Operations

Trump Unveils Midterm Strategy: Tax Cuts and "MAHA Movement" Take Center Stage, Targeting Pharma and Processed Food Sectors

Fosun Pharma's New Oral Drug for Vitiligo Gets Green Light for Phase III Trials

Genfleet-B Repurchases 75,000 Shares for HK$1.96 Million on September 9

CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug

MT Newswires Live

CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval in China

CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China

CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection

CSPC Pharma Wins China Clinical Trial Clearance for Syh9102 Goserelin Injection

CSPC Pharmaceutical - Goserelin Sustained-Release Injection (Syh9102 Injection) Obtains Clinical Trial Approval in China

THOMSON REUTERS

Fosun Pharma Spends HK$2.63 Million Buying Back Shares on September 9

Alibaba Health Information Technology Stock Slips 2.9% in Hong Kong

Sinopharm Group Stock Slips 2.1% in Hong Kong

BYD Electronic (International) Stock Sheds 2.4% in Hong Kong

Sino Biopharmaceutical Stock Slides 4.0% in Hong Kong, Underperforms Competitors

JD Health International Stock Sheds 3.7% in Hong Kong

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BK1515/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":893.4495,"timestamp":1789023610983,"preClose":912.77844,"halted":0,"volume":295795002,"delay":0,"changeRate":-0.021176,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-19.328918,"latestTime":"09-10 15:00:11","open":911.75104,"high":911.75104,"low":887.6602,"amount":2198175850,"amplitude":0.026393,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789027800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"pbRate":1.367616,"peRate":17.723048,"turnoverRate":0.00405,"increases":1,"decrements":16,"flats":0,"marketCap":602665005760,"floatMarketCap":500272798144},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":911.75104,"amplitude":0.026393,"preClose":912.77844,"low":887.6602,"pbRate":"1.367616","latestPrice":893.4495,"volume":295795002,"delay":0,"open":911.75104,"prevYearClose":1190.107,"prevWeekClose":936.431,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":925.365,"twentyDayClose":923.05,"sixtyDayClose":869.522,"secType":"PLATE","market":"HK","turnoverRate":0.00405,"peRate":17.723048,"marketCap":602665005760,"floatMarketCap":500272798144,"timestamp":1789023610983,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":1,"down":16,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1119404417","title":"Hong Kong Market Flash | CSPC Pharma Drops Over 4% as Lp(a) HORIZON Study Setback May Pressure Participants Including the Company","url":"https://stock-news.laohu8.com/highlight/detail?id=1119404417","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119404417?lang=en_us&edition=fundamental","pubTime":"2026-09-10 14:26","pubTimestamp":1789021579,"startTime":"0","endTime":"0","summary":"Shares of CSPC PHARMA (01093) fell more than 4%, and at the time of writing, they were down 2.69% to HK$8.855, with a turnover of HK$938 million. CLSA issued a research note stating that the latest...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","VXUS","LU1152091754.HKD","IE00B031HY20.USD","LU1152091168.USD","LU2039709279.SGD","LU0326950275.SGD","LU0315179316.USD","LU0880133367.SGD","HK0000165453.HKD","BK1521","IE0008368742.USD","LU0501845795.SGD","BK1515","LU1993786604.SGD","LU0140636845.USD","IE00B5MMRT66.SGD","KCAI","BK1191","LU1226287875.USD","IE00BZ08YT58.USD","LU0067412154.USD","LU1960683339.HKD","SG9999004220.SGD","BK4588","LU1226288253.USD","LU1328277881.USD","LU1951186391.HKD","IE00B543WZ88.USD","IE0008369823.USD","LU0072913022.USD","LU1226287529.USD","BK4585","IE00BZ08YS42.EUR","LU1226288170.HKD","LU1813983027.USD","LU1008478684.HKD","KURE","01093","LU1226287792.SGD","LU1807302812.USD","LU0314109678.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666987550","title":"CSPC Pharma's Clinical Data Presentations Could be Near-Term Share Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2666987550","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666987550?lang=en_us&edition=fundamental","pubTime":"2026-09-10 14:08","pubTimestamp":1789020480,"startTime":"0","endTime":"0","summary":"0608 GMT - CSPC Pharmaceutical's coming clinical data presentations over the next two months could serve as near-term share-price catalysts, say DBS Group Research's Mark Kong and Nico Chen in a note. The Chinese pharmaceutical group is scheduled to present on several key products, including Phase 3 clinical data for its GLP-1 fusion protein to treat obesity and diabetes, the analysts say. The company's voluntary participation is seen as a sign of confidence in the data, the analysts say. CSPC trades around 18X its 2027 price-to-earnings ratio, which is a roughly 28% discount to the peer average and offers an attractive entry point, they say. DBS reinstates its coverage of CSPC with a buy rating and 13.70 Hong Kong dollar target price. Shares fall 4.2% to HK$8.72.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU2039709279.SGD","LU1813983027.USD","LU0501845795.SGD","LU0315179316.USD","LU1960683339.HKD","IE00B031HY20.USD","LU0880133367.SGD","LU1807302812.USD","IE00B543WZ88.USD","LU0140636845.USD","LU0314109678.HKD","IE00BZ08YR35.GBP","LU1951186391.HKD","IE0008369823.USD","IE00B5MMRT66.SGD","SG9999004220.SGD","LU1226287529.USD","LU1993786604.SGD","LU1226287792.SGD","LU1328277881.USD","BK1515","LU1226287875.USD","LU1152091168.USD","LU1008478684.HKD","LU1152091754.HKD","LU1226288253.USD","IE00BZ08YT58.USD","LU0326950275.SGD","BK1521","IE0008368742.USD","KURE","01093","LU0072913022.USD","LU1226288170.HKD","IE00BZ08YS42.EUR","BK1191","LU0067412154.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170449208","title":"Morning Selloff Hits Mobile Supply Chain Stocks as Apple's Launch Fails to Offset Cost Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=1170449208","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170449208?lang=en_us&edition=fundamental","pubTime":"2026-09-10 11:19","pubTimestamp":1789010384,"startTime":"0","endTime":"0","summary":"Shares across the mobile phone supply chain are trading lower this morning, with the sector facing renewed margin concerns despite Apple's highly anticipated product unveiling. Q Tech (01478) has...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","LU1582986359.USD","LU1935043536.SGD","LU0889565833.HKD","LU2746668461.USD","LU2361044865.SGD","XLK","SG9999000418.SGD","LU1732799900.SGD","LU1934455277.USD","IE00B19Z8X17.USD","IXN","LU1839511570.USD","LU1400636574.HKD","LU0345770993.USD","HK0000320223.HKD","IE00BN8TJ469.HKD","LU1261432733.SGD","BK4533","IE00B19Z9505.USD","LU2552382132.HKD","LU0456855351.SGD","LU1506573853.SGD","IE00BK4W5M84.HKD","LU2286300806.USD","LU0553294199.USD","LU1242518931.SGD","LU1144417596.USD","LU1496350171.SGD","LU1803068979.SGD","LU2471134952.CNY","LU0077335932.USD","LU0238689110.USD","LU0868494708.USD","LU2430703251.USD","LU0256863811.USD","LU2487616109.SGD","LU0029864427.USD","BK4598","LU1642822529.SGD","IE00B1XK9C88.USD","IE000F7OJYX1.SGD","LU0265550359.USD","LU1206713676.USD","SG9999014542.SGD","AAPD","LU1791710400.SGD","CMAG","LU0861579265.USD","LU1244550221.USD","LU1244550494.USD","IE00BWXC8680.SGD","IE0004445239.USD","LU0868494617.USD","LU2237443465.HKD","LU1127390331.HKD","LU1852331112.SGD","LU0251132253.USD","LU0289961442.SGD","LU2237438978.USD","LU2087625088.SGD","LU2756315664.SGD","LU0882574139.USD","LU1064131342.USD","SG9999015986.USD","LU0795875086.SGD","LU0345769128.USD","LU0345768153.USD","IE00BSNM7G36.USD","LU2471134796.USD","LU0210536198.USD","LU1988902786.USD","LU2168564495.EUR","LU2430703095.HKD","LU0557290698.USD","IE00BMPRXR70.SGD","BK4573","HK0000819398.USD","SG9999014567.USD","LU1674673691.USD","IE0003U64NQ7.SGD","LU0320765059.SGD","LU1116320737.USD","AAPW","LU0912757837.SGD","LU2054465674.USD","LU2106854487.HKD","LU0950375773.USD","BK1179","LU0672654240.SGD","LU0211327993.USD","LU0127658192.USD","LU1267930573.SGD","LU0784385840.USD","HK0000306701.USD","LU2506951875.HKD","LU0738911758.USD","LU0784383803.USD","LU1232071149.USD","LU2237443382.USD","LU1868837136.USD","IE0005OL40V9.USD","LU0708994859.HKD","IE00BFSS7M15.SGD","LU2242650005.HKD","LU0353189680.USD","BK4581","LU2065171311.SGD","IE00BJJMRY28.SGD","LU0943347566.SGD","LU0354030511.USD","LU2023251221.USD","LU1066051225.USD","LU0265550946.USD","IE000WAW04H5.SGD","IE00B4YYXB79.USD","IE00BBT3K403.USD","ROM","SG9999002232.USD","LU2092937148.SGD","LU2860962120.EUR","LU2097344431.USD","IE00BN29S564.USD","IE000BZT7R73.USD","LU0708995401.HKD","IE00B7KXQ091.USD","IE00BJJMRX11.SGD","LU1720051108.HKD","LU2361044949.HKD","LU0345769631.USD","IE00BKDWB100.SGD","LU0289739343.SGD","LU0158827948.USD","LU0965509101.SGD","SGXZ31699556.SGD","LU0724617625.USD","BK1096","LU1206712785.SGD","LU2750360997.AUD","LU0149725797.USD","IE0034235295.USD","01478","LU2381873111.SGD","LU2133065610.SGD","LU2463028550.USD","BK1589","LU2237443978.SGD","LU2063271972.USD","LU0210528500.USD","LU0348723411.USD","LU0203201768.USD","LU0215105999.USD","LU2125154935.USD","BK4507","LU0957791311.USD","LU0314104364.USD","LU0823421416.USD","LU1037948897.HKD","LU0234572021.USD","BK4532","JGRO","BK4501","LU2065170008.USD","IE0001KFT4U8.USD","LU1935043452.HKD","METV","LU1674673428.USD","SGXZ80539844.SGD","LU2360032135.SGD","LU1291159041.SGD","IE0004086264.USD","LU0124676726.USD","LU1267930490.SGD","SG9999018865.SGD","LU1582987597.SGD","LU0274383008.USD","LU0109391861.USD","LU0133085943.USD","LU0964807845.USD","LU2471134879.HKD","LU2213496289.HKD","LU2458330243.SGD","LU0081259029.USD","LU0234570918.USD","LU0345768740.USD","LU0143551892.USD","LU1935042991.SGD","LU2111349929.HKD","LU1069344957.HKD","LU2047632596.USD","HK0000320264.USD","BK1540","LU1791710582.SGD","LU0256863902.USD","LU1989772840.SGD","LU0323591593.USD","LU0070302665.USD","FTEC","LU0661504455.SGD","LU2028103732.USD","LU0528227936.USD","IE0004091025.USD","IE000W1ABFV2.USD","LU1145028129.USD","LU0096362180.USD","LU2471134523.USD","LU1989771016.USD","BK1504","SG9999014559.SGD","IE00B5949003.HKD","IE0009356076.USD","LU0494093205.USD","LU2361045086.USD","LU2357305700.SGD","IE00B19Z8W00.USD","AAPB","LU2237443895.HKD","IE00BQXX3D17.EUR","SG9999014906.USD","LU0726765562.USD","LU0784384876.USD","LU2552382058.USD","BK4505","LU1066051811.HKD","HK0000306685.HKD","LU0069063385.USD","IE000Q6AESB8.SGD","LU1366333091.USD","LU2097344357.USD","BK4553","IE000MB6IJN5.SGD","LU1066053197.SGD","LU2250418816.HKD","LU0942090050.USD","LU1868836914.USD","BK1607","IE0034235303.USD","LU1582986433.USD","IE00BYXW3230.USD","SG9999018857.SGD","LU2087621335.USD","IE00B4JS1V06.HKD","LU0823417737.USD","HK0000914686.HKD","IOSX","LU0689626769.HKD","300433","SG9999015945.SGD","IE00BMPRXQ63.HKD","LU1400636657.SGD","BK4527","LU2347655156.SGD","VT","LU1267930730.SGD","LU1868836757.USD","LU0417517546.SGD","LU2237443549.SGD","LU0162691827.USD","LU1917777945.USD","LU2505996681.GBP","LU1202635105.USD","LU2083900584.USD","LU2077746001.SGD","LU0823434583.USD","LU0545039389.USD","SG9999014880.SGD","LU1551013425.SGD","LU2750360641.GBP","LU2347655073.USD","LU1244550577.SGD","LU0788109477.HKD","LU2125154778.USD","LU2462157665.USD","IE0000B7K699.USD","LU0310800379.SGD","IE00BQXX3C00.GBP","LU1720051017.SGD","LU0158827781.USD","LU0203202063.USD","LU2552382215.SGD","LU0011850046.USD","LU0154236417.USD","TTXU","LU1935042488.USD","HK0000914660.USD","LU2065169927.USD","BK1149","LU0985320562.USD","LU2592432038.USD","LU0823417653.USD","LU0949170426.SGD","LU2023250330.USD","LU0345770308.USD","LU2168563687.JPY","BK4588","LU1035775433.USD","LU1003077747.HKD","BK4170","LU0056508442.USD","LU2505996509.AUD","LU0097036916.USD","IE0009G5SDU7.USD","LU1868837300.USD","LU0689472784.USD","LU2458330169.SGD","LU0353189763.USD","LU0820562030.AUD","BK4585","LU1815333072.USD","LU0719512351.SGD","LU0080751232.USD","LU0683600562.USD","LU2264538146.SGD","SG9999014575.USD","LU1066051498.USD","LU2247934214.USD","LU0070217475.USD","LU0348767384.USD","LU2417539215.USD","SG9999015358.SGD","IE00BJTD4N35.SGD","LU2420271590.USD","LU2456880835.USD","LU0174119429.USD","LU0267386448.USD","LU2089284900.SGD","BK1580","LU1979441026.SGD","LU0957808578.USD","LU0170899867.USD","LU0096364046.USD","LU0310799852.SGD","SG9999015978.USD","BK4574","LU2089283258.USD","LU0061475181.USD","LU0965509010.AUD","LU2430703178.SGD","IE00BMPRXN33.USD","BK1582","IE00BFSS8Q28.SGD","IE00BJTD4V19.USD","AAPE","LU0053666078.USD","LU1037948541.HKD","LU0476273544.USD","GB00BDT5M118.USD","LU2023250843.SGD","SG9999002224.SGD","06613","LU0786609619.USD","LU2237443622.USD","LU1629891620.HKD","LU2954938101.SGD","LU0072461881.USD","LU3102509885.SGD","LU1934455863.HKD","LU0784385170.HKD","LU1804176565.USD","LU2543165471.USD","LU1699723380.USD","LU0348766576.USD","BK4512","BK1170","IE00B775H168.HKD","IE0004445015.USD","IE00BKVL7J92.USD","LU2896262040.SGD","BK1167","IE000YTNTUN2.SGD","LU0787776722.HKD","LU0316494557.USD","HK0000532082.HKD","APLY","IE00BDCRKT87.USD","LU1823568750.SGD","SG9999001424.SGD","BK4575","IE000KEQY171.SGD","LU0820561818.USD","LU2168564222.USD","LU2506952097.USD","LU0057025933.USD","LU2271345857.HKD","LU1366192091.USD","LU1914381329.SGD","LU0444973449.USD","BK4576","LU0210533765.USD","LU2242649171.HKD","LU0965509283.SGD","LU2506951958.HKD","SAAPLmain","BK4559","LU1814569148.SGD","ABFL","IE00B1BXHZ80.USD","LU2756315318.SGD","LU1778281490.HKD","LU1548497426.USD","LU1935043023.USD","LU1645745479.HKD","LU2236285917.USD","LU0823421333.USD","IE000ITXATA3.USD","LU2999663052.SGD","LU0079474960.USD","BK1515","LU2092627202.USD","LU0128525929.USD","LU2602419157.SGD","SG9999014898.SGD","LU0466842654.USD","LU1116320901.HKD","IE00B3SWFQ91.USD","LU1242518857.USD","LU2360106780.USD","IE00BQXX3F31.USD","LU1316542783.SGD","AAPY","BK4550","LU1046421795.USD","BK4534","LU0320765489.SGD","LU1670756490.USD","01415","BK4571","LU2265009873.SGD","LU2746668974.SGD","SG9999017495.SGD","LU0211328371.USD","LU0640476718.USD","MACW.SI","LU0511384066.AUD","LU0965508806.USD","LU0308772762.SGD","LU0048584097.USD","LU0642271901.SGD","VGT","LU1074936037.SGD","LU1815336760.USD","IE00B775SV38.USD","BK4579","LU1280957306.USD","LU1582987324.SGD","IE00BK4W5L77.USD","LU0109392836.USD","LU0208291251.USD","LU1934455194.USD","LU1119994496.HKD","LU2065171402.SGD","SG9999015952.SGD","LU2462591350.SGD","IE000SO60NU8.SGD","00285","BK4566","LU0472753341.HKD","LU2191332357.HKD","LU0072462426.USD","AAPL","LU0082616367.USD","LU0198837287.USD","LU1989772923.USD","LU1989764664.SGD","LU0354030438.USD","LU0823434740.USD","LU0444971666.USD","LU0061474960.USD","LU1974910355.USD","LU1400636491.USD","LU1551013342.USD","TYLG","LU0979878070.USD","LU2100268510.USD","LU2168564065.EUR","IE00BLSP4452.SGD","LU1235294995.USD","LU1301847155.USD","LU0949170772.SGD","LU2637965513.SGD","IE00BJLML261.HKD","LU1732800096.USD","IE00BZ1G4Q59.USD","LU0820561909.HKD","BK4592","IE00B3S45H60.SGD","LU2462591277.SGD","SPTE","LU1571399168.USD","LU1084165304.USD","IE00BDRTCR15.USD","LU2506952170.USD","BK4515","LU1496350502.SGD","AAPX","LU2461242641.AUD","LU1935042215.USD","LU2108987350.USD","LU0157215616.USD","LU1718418525.SGD","BK4554","LU2168564149.EUR","SG9999014914.USD","LU2023250504.SGD","LU0795875169.SGD","LU1868836591.USD","LU1989764748.USD","LU2403377893.USD","SG9999015341.SGD","LU0314106906.USD","LU2452424414.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175120307","title":"Ascletis Pharma Surges on US Obesity Drug Trial Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1175120307","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175120307?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:50","pubTimestamp":1789005025,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) shares jumped nearly 5% in early trading, before paring gains to a modest 0.50% increase, reaching HK$10.11 with turnover of HK$1.82 million. The company announced it has...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","01477","BK1191","BK1574","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169429326","title":"Pharmaceutical Firms Divest Assets to Bolster Core Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=1169429326","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169429326?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:12","pubTimestamp":1788966731,"startTime":"0","endTime":"0","summary":"A growing number of domestic listed pharmaceutical companies have recently disclosed asset disposal announcements, planning to sell partial or full equity stakes in their controlled subsidiaries....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","09939","FOSL","BK4202","BK1191","BK1593","BK1574","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145691069","title":"Trump Unveils Midterm Strategy: Tax Cuts and \"MAHA Movement\" Take Center Stage, Targeting Pharma and Processed Food Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1145691069","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145691069?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:44","pubTimestamp":1788961466,"startTime":"0","endTime":"0","summary":"President Trump has stepped up his campaign efforts ahead of the November midterm elections, adopting a familiar playbook of self-promotion that he has long relied upon. Despite approval ratings...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","159151","BK1574","BK1161","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108076077","title":"Fosun Pharma's New Oral Drug for Vitiligo Gets Green Light for Phase III Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1108076077","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108076077?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:21","pubTimestamp":1788956512,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. has announced that its oral candidate FXS5626 tablets (formerly project code AC-201) have received clinical trial approval from the National Medical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","BK0028","BK0096","BK0183","BK1515","BK1593","BK0175","BK0187","BK0060","BK1191","BK0012","600196","02196","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179497303","title":"Genfleet-B Repurchases 75,000 Shares for HK$1.96 Million on September 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1179497303","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179497303?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:14","pubTimestamp":1788956052,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that on September 9, 2026, the company spent HK$1.9608 million to repurchase 75,000 shares.The buyback transaction reflects the company's ongoing capital management...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","09939","BK1161","BK1574","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587876","title":"CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587876","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587876?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951640,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group's (HKG:1093) SYH9102 injection obtained clinical trial approval from China's National Medical Products Administration.The clinical indication is for patients with solid tumors, according to a Wednesday Hong Kong bourse filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0880133367.SGD","LU1152091754.HKD","KURE","IE00B5MMRT66.SGD","HK0000165453.HKD","LU0315179316.USD","SG9999004220.SGD","01093","LU0314109678.HKD","LU1226287792.SGD","LU1226288170.HKD","LU1152091168.USD","BK1521","IE0008368742.USD","IE0008369823.USD","LU1813983027.USD","IE00BZ08YT58.USD","LU0140636845.USD","BK1515","IE00BZ08YR35.GBP","LU1807302812.USD","LU1328277881.USD","BK1191","LU1226288253.USD","LU0067412154.USD","IE00BZ08YS42.EUR","LU0326950275.SGD","LU1951186391.HKD","LU1226287529.USD","LU1008478684.HKD","IE00B031HY20.USD","LU1993786604.SGD","LU0072913022.USD","LU2039709279.SGD","LU1226287875.USD","IE00B543WZ88.USD","LU0501845795.SGD","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666828235","title":"CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2666828235","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666828235?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:34","pubTimestamp":1788950057,"startTime":"0","endTime":"0","summary":"BRIEF-CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval In ChinaSept 9 (Reuters)-CSPC PHARMACEUTICAL GROUP LIMITED1093.HK:ROTIGOTINE LONG-ACTING INJECTION (SYH9087 INJECTION) OBTAINS CLINICAL TRIAL APPROVAL IN CHINAFurther company coverage:1093.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN45104B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","LU1813983027.USD","LU1152091168.USD","LU0072913022.USD","LU1226288253.USD","LU1226288170.HKD","LU1807302812.USD","IE00BZ08YT58.USD","LU0501845795.SGD","LU1226287792.SGD","SG9999004220.SGD","IE00B5MMRT66.SGD","LU0067412154.USD","LU1960683339.HKD","LU0326950275.SGD","LU0315179316.USD","HK0000165453.HKD","LU1008478684.HKD","BK1191","KURE","LU0880133367.SGD","IE0008369823.USD","LU1226287875.USD","IE0008368742.USD","LU1152091754.HKD","LU1993786604.SGD","LU1951186391.HKD","LU1328277881.USD","01093","LU2039709279.SGD","IE00B031HY20.USD","IE00BZ08YR35.GBP","BK1521","LU1226287529.USD","LU0314109678.HKD","BK1515","LU0140636845.USD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151768833","title":"CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1151768833","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151768833?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:12","pubTimestamp":1788948739,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its self-developed gonadotropin-releasing hormone (GnRH) receptor agonist, Goserelin Extended-Release Injection (SYH9102 Injection), has received approval from...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU1951186391.HKD","MDTX","LU0501845795.SGD","BK1521","LU0072913022.USD","LU1152091168.USD","IE00B031HY20.USD","BK1191","LU1813983027.USD","SG9999004220.SGD","PSYK","LU1960683339.HKD","IE0008369823.USD","IE00B5MMRT66.SGD","LU1226287792.SGD","LU2039709279.SGD","BK1515","IE00B543WZ88.USD","LU0067412154.USD","IE00BZ08YR35.GBP","LU0880133367.SGD","LU1226287529.USD","IE0008368742.USD","LU0315179316.USD","LU1008478684.HKD","LU1152091754.HKD","IE00BZ08YS42.EUR","LU1226288253.USD","HK0000165453.HKD","LU1226288170.HKD","LU1807302812.USD","BMED","LU1993786604.SGD","LU1328277881.USD","LU1226287875.USD","IBBJ","LU0326950275.SGD","LU0314109678.HKD","IE00BZ08YT58.USD","LU0140636845.USD","01093","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100647125","title":"CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1100647125","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100647125?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:12","pubTimestamp":1788948739,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its self-developed gonadotropin-releasing hormone (GnRH) receptor agonist, Goserelin Extended-Release Injection (SYH9102 Injection), has received approval from...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0880133367.SGD","LU1152091754.HKD","MDTX","KURE","IBBJ","IE00B5MMRT66.SGD","HK0000165453.HKD","LU0315179316.USD","SG9999004220.SGD","01093","LU0314109678.HKD","LU1226287792.SGD","LU1226288170.HKD","PSYK","LU1152091168.USD","BK1521","IE0008368742.USD","IE0008369823.USD","BMED","LU1813983027.USD","IE00BZ08YT58.USD","LU0140636845.USD","BK1515","IE00BZ08YR35.GBP","LU1807302812.USD","LU1328277881.USD","BK1191","LU1226288253.USD","LU0067412154.USD","IE00BZ08YS42.EUR","LU0326950275.SGD","LU1951186391.HKD","LU1226287529.USD","LU1008478684.HKD","IE00B031HY20.USD","LU1993786604.SGD","LU0072913022.USD","LU2039709279.SGD","LU1226287875.USD","IBBQ","IE00B543WZ88.USD","LU0501845795.SGD","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666610584","title":"CSPC Pharma Wins China Clinical Trial Clearance for Syh9102 Goserelin Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2666610584","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666610584?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:11","pubTimestamp":1788948662,"startTime":"0","endTime":"0","summary":"CSPC Pharma wins China clinical trial clearance for SYH9102 goserelin injectionCSPC Pharmaceutical Group received China NMPA clearance to start clinical trials of its goserelin sustained-release injec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL9BYJhM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","LU1152091754.HKD","IE00B031HY20.USD","LU1152091168.USD","LU2039709279.SGD","LU0326950275.SGD","LU0315179316.USD","LU0880133367.SGD","HK0000165453.HKD","BK1521","IE0008368742.USD","LU0501845795.SGD","BK1515","LU1993786604.SGD","LU0140636845.USD","IE00B5MMRT66.SGD","BK1191","LU1226287875.USD","IE00BZ08YT58.USD","LU0067412154.USD","LU1960683339.HKD","SG9999004220.SGD","LU1328277881.USD","LU1226288253.USD","LU1951186391.HKD","IE00B543WZ88.USD","IE0008369823.USD","LU0072913022.USD","LU1226287529.USD","IE00BZ08YS42.EUR","LU1226288170.HKD","LU1813983027.USD","LU1008478684.HKD","KURE","01093","LU1226287792.SGD","LU1807302812.USD","LU0314109678.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584556","title":"CSPC Pharmaceutical - Goserelin Sustained-Release Injection (Syh9102 Injection) Obtains Clinical Trial Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584556","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584556?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:07","pubTimestamp":1788948434,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN450126:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1960683339.HKD","LU1226287875.USD","KURE","LU0067412154.USD","LU1328277881.USD","LU1152091168.USD","LU1226287529.USD","LU0314109678.HKD","IE00B031HY20.USD","LU0880133367.SGD","LU1951186391.HKD","BK1521","LU0072913022.USD","IE00BZ08YR35.GBP","LU0501845795.SGD","LU1008478684.HKD","LU0326950275.SGD","LU1226288170.HKD","LU1152091754.HKD","IE00BZ08YT58.USD","IE00B5MMRT66.SGD","LU1807302812.USD","LU0315179316.USD","LU0140636845.USD","LU2039709279.SGD","BK1515","LU1226287792.SGD","IE00B543WZ88.USD","BK1191","01093","LU1993786604.SGD","LU1813983027.USD","LU1226288253.USD","SG9999004220.SGD","IE00BZ08YS42.EUR","IE0008368742.USD","IE0008369823.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156059034","title":"Fosun Pharma Spends HK$2.63 Million Buying Back Shares on September 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1156059034","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156059034?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:06","pubTimestamp":1788948375,"startTime":"0","endTime":"0","summary":"Fosun Pharma (02196) has announced that on September 9, 2026, the company repurchased 152,500 shares for a total consideration of HK$2.63 million.The buyback transaction was disclosed in an official...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK0175","02196","BK0012","BK1515","BK0239","BK0188","BK0183","BK0187","BK0196","BK0028","BK0060","BK1191","600196","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666585460","title":"Alibaba Health Information Technology Stock Slips 2.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666585460","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666585460?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:32","pubTimestamp":1788942720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Alibaba Health Information Technology Ltd. shed 2.9% to 3.05 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.This was the stock's second consecutive day of losses.Alibaba Health Information Technology Ltd. closed 61% short of its 52-week high of HK$7.91, which the company reached Jan. 14.The stock underperformed when compared to some of its competitors, as HKT Trust & HKT Ltd. fell 0.1%.Trading volume totaled 82.0 million shares, compared to the 50-day average of 97.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1571","MCHmain","BK1617","BK1584","513600","HSTECH","HSI","83115","HHImain","BK1591","BK1501","00241","09115","07200","07300","BK1515","HK0000165453.HKD","MHImain","03115","BK1615","BK1502","07500","03037","82800","03419","BK1247","BK1189","02800","BK1142","02833","BK1610","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458549","title":"Sinopharm Group Stock Slips 2.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458549","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458549?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:32","pubTimestamp":1788942720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slid 2.1% to 15.70 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.The stock's fall snapped a four-day winning streak.Sinopharm Group Co. Ltd. closed 30% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.2%.Trading volume totaled 5.9 million shares, compared to the 50-day average of 5.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK4175","02196","BK0188","01099","BK0096","LU1115378108.SGD","BK0196","SHTDY","BK0175","LU0640798160.USD","BK0028","BK0060","BK1593","BK0012","600196","BK1500","BK0187","BK1197","BK1191","BK0239","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666427585","title":"BYD Electronic (International) Stock Sheds 2.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666427585","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666427585?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:32","pubTimestamp":1788942720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. slipped 2.4% to 24.90 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.This was the stock's second consecutive day of losses.BYD Electronic  Co. Ltd. closed 44% below its 52-week high of HK$44.60, which the company reached Oct. 2.Despite its losses, the stock outperformed some of its competitors, as Times Universal Group Holdings Ltd. fell 3.1%.Trading volume totaled 9.3 million shares, compared to the 50-day average of 12.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1540","00285","BK1582","BK1589","BK1149","LU0348767384.USD","LU0348766576.USD","BK1504","BK1167","BK1607","LU0274383008.USD","BK1515","BK1580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666854905","title":"Sino Biopharmaceutical Stock Slides 4.0% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666854905","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666854905?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:31","pubTimestamp":1788942660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 4.0% to 5.61 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.Sino Biopharmaceutical Ltd. closed 38% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 3.4% and Amgen Inc. remained unchanged.Trading volume totaled 97.7 million shares, compared to the 50-day average of 100.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IBB","LU0289739699.SGD","IE00B2B36J28.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","BK1191","LU0889565916.HKD","IE0002141913.USD","BK1521","IE00BZ08YS42.EUR","LU2089984988.USD","LU1023059063.AUD","PJP","BK1589","IE00BZ08YR35.GBP","LU2242646821.SGD","BK4599","BK4533","BBH","LU1571399168.USD","AMGN","BK4139","BK4534","LU2242652126.USD","LU2468319806.SGD","TBXU","BK4581","HK0000165453.HKD","IE00B4R5TH58.HKD","IE0009355771.USD","BK4566","BK4588","01177","LU0058720904.USD","LU0122379950.USD","LU0320765992.SGD","LU1983299246.USD","IBBQ","BK1515","BK4585","LU1057294990.SGD","LU2112291526.USD","LU0868494617.USD","SG9999001440.SGD","BIB","IE00BJT1NW94.SGD","IE00BZ08YT58.USD","PBE","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666585445","title":"JD Health International Stock Sheds 3.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666585445","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666585445?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:30","pubTimestamp":1788942600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. shed 3.7% to 35.26 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.This was the stock's third consecutive day of losses.JD Health International Inc. closed 51% short of its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 20.2 million shares, compared to the 50-day average of 9.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ62798434.SGD","BK1247","BK1571","BK1589","BK1583","LU0051755006.USD","LU0456827905.SGD","SGXZ86797644.SGD","BK1142","06618","BK1515","BK1591","BK1615","86618"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":1,"totalSize":205,"code":"91000000","status":"200"}]}}